Definitions of the levels of evidence (I-V) and grades of recommendation (A-C, I) are provided at the end of the "Major Recommendations" field.
Note from the American Academy of Orthopaedic Surgeons (AAOS): This guideline was explicitly developed to include only treatments less invasive than knee replacement (arthroplasty). This summary does not contain rationales that explain how and why these recommendations were developed nor does it contain the evidence supporting these recommendations. All readers of this summary are strongly urged to consult the full guideline and evidence report for this information (see the "Guideline Availability" and "Availability of Companion Documents" fields). The authors are confident that those who read the full guideline and evidence report will also see that the recommendations were developed using systematic evidence-based processes designed to combat bias, enhance transparency, and promote reproducibility. This summary of recommendations is not intended to stand alone. Treatment decisions should be made in light of all circumstances presented by the patient. Treatments and procedures applicable to the individual patient rely on mutual communication between patient, physician and other healthcare practitioners.
Patient Education and Lifestyle Modification
Recommendation 1
The authors suggest patients with symptomatic osteoarthritis (OA) of the knee be encouraged to participate in self-management educational programs such as those conducted by the Arthritis Foundation, and incorporate activity modifications (e.g., walking instead of running; alternative activities) into their lifestyle. (Grade B, Level II)
Recommendation 2
Regular contact to promote self-care is an option for patients with symptomatic OA of the knee. (Grade C, Level IV)
Recommendation 3
The authors recommend patients with symptomatic OA of the knee, who are overweight (as defined by a body mass index [BMI] > 25), should be encouraged to lose weight (a minimum of five percent [5%] of body weight) and maintain their weight at a lower level with an appropriate program of dietary modification and exercise. (Grade A, Level I)
Rehabilitation
Recommendation 4
The authors recommend patients with symptomatic OA of the knee be encouraged to participate in low-impact aerobic fitness exercises. (Grade A, Level I)
Recommendation 5
Range of motion/flexibility exercises are an option for patients with symptomatic OA of the knee. (Grade C, Level V)
Recommendation 6
The authors suggest quadriceps strengthening for patients with symptomatic OA of the knee. (Grade B, Level II)
Mechanical Interventions
Recommendation 7
The authors suggest patients with symptomatic OA of the knee use patellar taping for short term relief of pain and improvement in function. (Grade B, Level II)
Recommendation 8
The authors suggest lateral heel wedges not be prescribed for patients with symptomatic medial compartmental OA of the knee. (Grade B, Level II)
Recommendation 9
The authors are unable to recommend for or against the use of a brace with a valgus directing force for patients with medial uni-compartmental OA of the knee. (Inconclusive, Level II)
Recommendation 10
The authors are unable to recommend for or against the use of a brace with a varus directing force for patients with lateral uni-compartmental OA of the knee. (Inconclusive, Level V)
Complementary and Alternative Therapy
Recommendation 11
The authors are unable to recommend for or against the use of acupuncture as an adjunctive therapy for pain relief in patients with symptomatic OA of the knee.
(Inconclusive, Level I)
Recommendation 12
The authors recommend glucosamine and/or chondroitin sulfate or hydrochloride not be prescribed for patients with symptomatic OA of the knee. (Grade A, Level I)
Pain Relievers
Recommendation 13
The authors suggest patients with symptomatic OA of the knee receive one of the following analgesics for pain unless there are contraindications to this treatment:
- Acetaminophen [not to exceed 4 grams per day]
- Non-steroidal anti inflammatory drugs (NSAIDs)
(Grade B, Level II)
Recommendation 14
The authors suggest patients with symptomatic OA of the knee and increased gastrointestinal (GI) risk (Age ≥ 60 years, comorbid medical conditions, history of peptic ulcer disease, history of GI bleeding, concurrent corticosteroids, and/or concomitant use of anticoagulants) receive one of the following analgesics for pain:
- Acetaminophen [not to exceed 4 grams per day]
- Topical NSAIDs
- Nonselective oral NSAIDs plus gastro-protective agent
- Cyclooxygenase-2 inhibitors
(Grade B, Level II)
Intra-Articular Injections
Recommendation 15
The authors suggest intra-articular corticosteroids for short-term pain relief for patients with symptomatic OA of the knee. (Grade B, Level II)
Recommendation 16
The authors cannot recommend for or against the use of intra-articular hyaluronic acid for patients with mild to moderate symptomatic OA of the knee. (Inconclusive, Level I and II)
Needle Lavage
Recommendation 17
The authors suggest that needle lavage not be used for patients with symptomatic OA of the knee. (Grade B, Level I and II)
Surgical Intervention
Recommendation 18
The authors recommend against performing arthroscopy with debridement or lavage in patients with a primary diagnosis of symptomatic OA of the knee. (Grade A, Level I and II)
Recommendation 19
Arthroscopic partial meniscectomy or loose body removal is an option in patients with symptomatic OA of the knee who also have primary signs and symptoms of a torn meniscus and/or a loose body. (Grade C, Level V)
Recommendation 20
The authors cannot recommend for or against an osteotomy of the tibial tubercle for patients with isolated symptomatic patello-femoral osteoarthritis. (Inconclusive, Level V)
Recommendation 21
Realignment osteotomy is an option in active patients with symptomatic unicompartmental OA of the knee with malalignment. (Grade C, Level IV and V)
Recommendation 22
The authors suggest against using a free-floating interpositional device for patients with symptomatic unicompartmental OA of the knee. (Grade B, Level IV)
Definitions:
Levels of Evidence for Primary Research Question1
Types of Studies |
|
Therapeutic Studies
Investigating the results of treatment
|
Prognostic Studies
Investigating the effects of a patient characteristic on the outcome of disease
|
Diagnostic Studies
Investigating a diagnostic test
|
Economic and Decision Analyses
Developing an economic or decision model
|
Level I |
- High quality randomized trial (RCT) with statistically significant difference but narrow confidence intervals
- Systematic Review2 of Level I RCTs (and study results were homogenous3)
|
- High quality prospective study4 (all patients were enrolled at the same point in their disease with ≥80% follow-up of enrolled patients)
- Systematic review2 of Level I studies
|
- Testing of previously developed diagnostic criteria on consecutive patients (with universally applied reference "gold" standard)
- Systematic review2 of Level I studies
|
- Sensible costs and alternatives; values obtained from many studies; with multiway sensitivity analyses
- Systematic review2 of Level I studies
|
Level II |
- Lesser quality RCT (e.g. <80% follow-up, no blinding, or improper randomization)
- Prospective4 comparative study5
- Systematic review 2 of Level II studies or Level I studies with inconsistent results
|
- Retrospective6 study
- Untreated controls from an RCT
- Lesser quality prospective study (e.g. patients enrolled at different points in their disease or <80% follow-up)
- Systematic review2 of Level II studies
|
- Development of diagnostic criteria on consecutive patients (with universally applied reference "gold" standard)
- Systematic review2 of Level II studies
|
- Sensible costs and alternatives; values obtained from limited studies; with multiway sensitivity analyses
- Systematic review2 of Level II studies
|
Level III |
- Case control study7
- Retrospective6 comparative study5
- Systematic review2 of Level III studies
|
|
- Study of non-consecutive patients; without consistently applied reference "gold" standard
- Systematic review2 of Level III studies
|
- Analyses based on limited alternatives and costs; and poor estimates
- Systematic review2 of Level III studies
|
Level IV |
Case Series8 |
Case Series |
- Case-control study
- Poor reference standard
|
- Analysis with no sensitivity analyses
|
Level V |
Expert Opinion |
Expert Opinion |
Expert Opinion |
Expert Opinion |
- A complete assessment of quality of individual studies requires critical appraisal of all aspects of the study design.
- A combination of results from two or more prior studies.
- Studies provided consistent results.
- Study was started before the first patient enrolled.
- Patients treated one way (e.g., cemented hip arthroplasty) compared with a group of patients treated in another way (e.g., uncemented hip arthroplasty) at the same institution.
- The study was started after the first patient enrolled.
- Patients identified for the study based on their outcome, called "cases" (e.g., failed total hip arthroplasty) are compared to those who did not have outcome, called "controls";(e.g., successful total hip arthroplasty).
- Patients treated one way with no comparison group of patients treated in another way.
Grading the Recommendations
A: Good evidence (Level I Studies with consistent finding) for or against recommending intervention.
B: Fair evidence (Level II or III Studies with consistent findings) for or against recommending intervention.
C: Poor quality evidence (Level IV or V) for or against recommending intervention.
I: There is insufficient or conflicting evidence not allowing a recommendation for or against intervention.